Last, we synthesized gETL NPs with loading of GM‐CSF and/or docetaxel (DTX) and characterized them for mPC treatment in both cell line‐derived xenografts (CDX) and patient‐derived tumor xenografts (PDX). Here, CSF2 is linked to neoplasm.